Martin McLaughlin
- Oncology top 5%
- Molecular Biology top 10%
- Immunology top 5%
- Genetics top 10%
- Pulmonary and Respiratory Medicine top 10%
- Co-authors
- Kevin J. HarringtonMalin PedersenMagnus T. DillonAlan MelcherEmmanuel C. PatinAnna WilkinsBrendan GilmoreSean P. Gorman
- Topics
- Virus-based gene therapy research (12 papers)DNA Repair Mechanisms (7 papers)CAR-T cell therapy research (7 papers)
- Cited by
- OncologyCatalysisImmunology
- Partner nations
- United KingdomUnited StatesCanada
In The Last Decade
Martin McLaughlin
36 papers receiving 2.1k citations
Hit Papers
Peers
Comparison fields: 5 of 122
- Oncology 834
- Molecular Biology 818
- Immunology 474
- Genetics 296
- Pulmonary and Respiratory Medicine 204
Countries citing papers authored by Martin McLaughlin
This map shows the geographic impact of Martin McLaughlin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Martin McLaughlin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Martin McLaughlin more than expected).
Fields of papers citing papers by Martin McLaughlin
This network shows the impact of papers produced by Martin McLaughlin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Martin McLaughlin. The network helps show where Martin McLaughlin may publish in the future.
Co-authorship network of co-authors of Martin McLaughlin
This figure shows the co-authorship network connecting the top 25 collaborators of Martin McLaughlin. A scholar is included among the top collaborators of Martin McLaughlin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Martin McLaughlin. Martin McLaughlin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 0 | |
| 3 | 13 | |
| 4 | 1 | |
| 5 | Inflammatory microenvironment remodelling by tumour cells after radiotherapybreakdown → | 601 |
| 6 | 24 | |
| 7 | 24 | |
| 8 | 18 | |
| 9 | 23 | |
| 10 | 146 | |
| 11 | 17 | |
| 12 | 20 | |
| 13 | 40 | |
| 14 | 82 | |
| 15 | 46 | |
| 16 | 38 | |
| 17 | 31 | |
| 18 | 44 | |
| 19 | 62 | |
| 20 | 118 |
About Martin McLaughlin
Martin McLaughlin is a scholar working on Geriatrics and Gerontology, Oncology and Biotechnology, having authored 38 papers that have together received 2.1k indexed citations. Recurring topics across this work include Virus-based gene therapy research (12 papers), DNA Repair Mechanisms (7 papers) and CAR-T cell therapy research (7 papers). The work is most often cited by research in Oncology (834 citations), Catalysis (167 citations) and Immunology (474 citations). Martin McLaughlin has collaborated with scholars based in United Kingdom, United States and Canada. Frequent co-authors include Kevin J. Harrington, Malin Pedersen, Magnus T. Dillon, Alan Melcher, Emmanuel C. Patin, Anna Wilkins, Brendan Gilmore, Sean P. Gorman, Joan Kyula and Garry Laverty. Their work appears in journals such as Journal of Biological Chemistry, Nature reviews. Cancer and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.